files/journal/2022-09-03_18-51-40-000000_599.png

Research Journal of Medical Sciences

ISSN: Online 1993-6095
ISSN: Print 1815-9346
297
Views
33
Downloads

Prevalence of Oral Mucosal Lesions in Patients with Autoimmune Diseases: A Cross‐Sectional Survey

B. S. Sindhu, K. Prathap Kumar, G.P. Chandrasekhar Naidu and S. Khallilullah
Page: 85-91 | Received 16 Aug 2023, Published online: 03 Sep 2023

Full Text Reference XML File PDF File

Abstract

Oral mucosal lesions (OMLs) are frequently observed clinical manifestations in various diseases but their prevalence in patients with autoimmune diseases remains poorly understood. This study aimed to evaluate the prevalence of OMLs in patients diagnosed with autoimmune diseases and to understand their clinical significance. To assess the prevalence of oral mucosal lesions (OMLs) in patients diagnosed with autoimmune diseases and to explore any correlation with the type of autoimmune condition. In this cross‐sectional survey, 400 patients diagnosed with various autoimmune diseases from a tertiary care center were examined. A meticulous oral examination was performed to identify OMLs. Data regarding the specific autoimmune disease, its duration and associated treatments were documented. The prevalence of OMLs was computed and statistical analysis was performed to determine the relationship between autoimmune diseases and OML occurrence. Of the 400 patients, 152 (38%) exhibited OMLs. Lichen planus, aphthous ulcers and pemphigoid lesions were the predominant findings. Individuals with systemic lupus erythematosus (SLE) and Sjögren's syndrome were observed to have a greater prevalence of OMLs, at 55 and 50% respectively. A significant correlation was identified between the duration of the autoimmune disease and the emergence of OMLs. However, no discernible association was found between the occurrence of OMLs and the specific treatments received by the patients. A significant portion of patients with autoimmune diseases present with OMLs. Regular oral health check‐ups can be crucial for early detection and management of these lesions in such patients. Further in‐depth studies can provide insights into the underlying mechanisms and potential treatment modalities.


How to cite this article:

B. S. Sindhu, K. Prathap Kumar, G.P. Chandrasekhar Naidu and S. Khallilullah. Prevalence of Oral Mucosal Lesions in Patients with Autoimmune Diseases: A Cross‐Sectional Survey.
DOI: https://doi.org/10.36478/10.59218/makrjms.2023.8.85.91
URL: https://www.makhillpublications.co/view-article/1815-9346/10.59218/makrjms.2023.8.85.91